Glycomine
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Glycomine is a company in biotechnology, pharmaceutical, therapeutics based in San Francisco Bay Area, West Coast, Western US, founded in 2013.
Its activity falls under biotechnology, pharmaceutical, therapeutics; the profile below is assembled from public directory data.
Its base of operations is San Francisco Bay Area, West Coast, Western US.
It is recorded at the Series_B stage.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $80M in funding.
| Sector | Biotechnology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Country | US |
| Founded | 2013 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $80,000,000 |
Website: glycomine.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account